Empowered Products, Inc. (EMPO) Research

Empowered Products, Inc., along with its affiliated entities, specializes in the creation, marketing, and distribution of personal care items. Its primary markets encompass the United States, Europe, and Asia. These offerings typically include topical gels, lotions, and oils, which the company claims are formulated to sharpen mental acuity and strengthen personal connections. Its extensive product portfolio features distinctive skin lubricants marketed under two main brands: PINK, catering to women, and GUN OIL, developed for men. Under the GUN OIL brand, products for men range from silicone-based (e.g., GUN OIL Silicone) and water-based (e.g., GUN OIL H2O) interactive lubricants to hybrid formulations (e.g., GUN OIL Force Recon). The line also includes specialized options like gelatinous lubricants for personal toys (e.g., GUN OIL Gel) and personal toy cleaners. Similarly, the PINK line for women offers a diverse selection, including silicone (e.g., PINK Silicone) and water-based (e.g., PINK Water) interactive lubricants, as well as unique products like exothermic massage lubricants (e.g., Hot PINK), hybrid creams (e.g., PINK Indulgence Crème), and personal toy cleaners. Distribution occurs through multiple channels, encompassing direct sales to retail partners and directly to end-consumers via the company's proprietary online Wellness Stores. Its corporate headquarters are situated in Las Vegas, Nevada.

Market snapshot

Symbol
EMPO
Price
$0.00
Day change
0.00%
Market cap
$25.1K
52-week range
0.0001-0.0004
Sector
Consumer Defensive
Industry
Household & Personal Products

Peer companies

  • Avix Technologies, Inc. (AVIX)
  • Science to Consumers, Inc. (BEUT)
  • Good Life China Corporation (GLCC)
  • Happy Town Holdings Inc. (HPTN)
  • NXT Nutritionals Holdings, Inc. (NXTH)
  • Oragin Foods Inc. (OGGFF)
  • Smart for Life, Inc. (SMFL)
  • Tigrent Inc. (TIGE)

Open Empowered Products, Inc. (EMPO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.